The Ontario Pharmacists’ Association (OPA) called an Ontario government plan to cut pharmacy reimbursement for generic drugs misguided, noting that such a move would mark the second such reduction in two years.
BioScrip Inc. has named Hai Tran as senior vice president, chief financial officer and treasurer. The company said late Monday that Tran is slated to take over the CFO post on May 14 from Mary Jane Graves, who has been serving as interim CFO and treasurer since January 2011. Plans call for MJ
Anheuser-Busch is expanding its Bud Light lineup with Bud Light Lime Lime-a-Rita, which the company said gives a fresh twist to a classic summer cocktail, the margarita. Bud Light Lime also now sports new packaging.
AstraZeneca plans to buy Ardea Biosciences Inc. in a cash deal valued at $1.26 billion. The companies said Monday that they expect the transaction to close in the second or third quarter of this year. The clinically most advanced product candidate of Ardea, a San Diego-based biotech firm focused on
Pfizer has unveiled a deal to sell its pediatric nutrition business to Nestle for $11.85 billion in cash. The pharmaceuticals giant said Monday that the divestiture of Pfizer Nutrition, which had revenue of about $2.
Watson Pharmaceuticals Inc. has launched an authorized generic version of Fortamet, a treatment for type 2 diabetes. Watson began shipping the product late last week.
Chain drug stores have responded well to the changing marketplace over the past year and bolstered their prospects for growth in 2012, industry analysts say.
The National Association of Chain Drug Stores has elected Greg Wasson, president and chief executive officer of Walgreen Co., as the new NACDS chairman and announced the election of other new officers, a new executive committee member and five new board members.
A large percentage of Americans don’t know the government-recommended vaccinations for their age and health condition, according to a Walgreen Co. survey. Walgreens said Monday that the online poll of over 1,000 U.S.
Government and health care decision makers are exhibiting a rising appreciation of the role that community pharmacy services can play in improving the quality and lowering the cost of health care, National Association of Chain Drug Stores president and chief executive officer Steve Anderson said at
The Jean Coutu Group has sold more than 20% of its equity stake in Rite Aid Corp. Jean Coutu said late Friday that it completed the sale of 56 million, or nearly 24%, of its 234.4 million common shares of Rite Aid. The sale of the shares lowers Jean Coutu’s interest in
As National Association of Chain Drug Stores chairman Bob Loeffler sees it, the record-breaking participation in this year’s NACDS RxImpact Day on Capitol Hill shows the effect that proactive member engagement can have. H-E-B’s Bob Loeffler, chairman of NACDS.
CVS/pharmacy is focused on growing its front-end business as it builds on the strong foundation established in recent years.
A federal judge heard arguments this month in the lawsuit seeking to stop the merger of Express Scripts Inc. and Medco Health Solutions Inc. U.S.
With the Centers for Medicare & Medicaid Services (CMS) expected to issue a final rule on Medicaid pharmacy reimbursements next year, community pharmacy advocates earlier this month weighed in on the proposal.
Continuing its financial recovery, Rite Aid Corp. turned in improved results for its fiscal 2012 fourth quarter and full year. In the 13-week quarter ended March 3, revenue totaled $7.1 billion, up 10.7% from the prior-year period. Same-store sales grew 3%, reflecting gains of 1.
